Explore more publications!

Washington State Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Washington State Gazette.

Press releases published on November 5, 2025

Scientists Complete First Drafts of Developing Mammalian Brain Cell Atlases
AI Adoption Outpaces Proficiency: 300,000 Global Assessments Show Three Critical Gaps
Costco Wholesale Corporation Reports October Sales Results
Remitly to Host Investor Day on December 9, 2025
Remitly Reports Third Quarter 2025 Results Above Outlook and Raises Full Year 2025 Outlook
Adaptive Biotechnologies Reports Third Quarter 2025 Financial Results
Talking Rain’s Sparkling Ice recognized as Best Global Brand by 425 Business magazine readers
Emerald Heights Social Accountability Committee Donates $305,000 to Support 15 Charities Benefiting Local Communities
MLTX INVESTOR NOTICE: MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman
JHX INVESTOR ALERT: James Hardie Industries (JHX) Lawsuit Alleges Securities Fraud Over Inventory Misstatements -- Hagens Berman
WatchGuard Appoints Joe Smolarski Chief Executive Officer to Lead a New Chapter in Platform-Driven Cybersecurity Innovation
aTyr Pharma, Inc. (ATYR) Failed Drug Trial Spurs Securities Lawsuit; Class Period Significantly Enlarged -- Hagens Berman
KBR 13-DAY DEADLINE ALERT: KBR, Inc. (KBR) Cuts 2025 Revenue Due to TRANSCOM Termination, Securities Class Action Looms–Hagens Berman
Synopsys, Inc. (SNPS) Faces Securities Class Action Amid Q325 Results Revealing IP Business Problems -- Hagens Berman
firmly Unveils Unified “Buy Now” Platform to Power the Future of Agentic Commerce
IP Strategy Announces First Investor Day to be held on Thursday, November 20, 2025
Avista Corp. Reports Strong Q3 2025 Financial Results, Confirms 2025 Earnings Guidance
Pluristyx Executes Key Commercial Clinical Use Licenses for iPSC Portfolio, Enabling Novel Therapies for Regenerative Medicine and Neurological Disease Therapeutics

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions